BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Molecular Partners (MOLN – Research Report), ...

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., March 04, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that ...

The stock market is waiting on a follow through day. Miami's eMerge Americas conference may provide some surprise energy for ...

Lucera, 57 years old, joins Dyne, a clinical-stage muscle disease company, from Editas Medicine, where he has served as CFO since May 2023, Dyne said Thursday. He has also held the top finance jobs at ...

UN says renewed Gaza violence makes hostage return more distant The United Nations said on Thursday that each day of renewed violence in Gaza makes the return of the remaining hostages held there ...

Summit Therapeutics Inc., a biopharmaceutical company ... and societal friendly medicinal therapies in the United States, and the United Kingdom. Its lead development candidate, ivonescimab ...

After hours: March 17 at 4:42:31 PM EDT Loading Chart for UTHR ...

A new report claims Ayden Heaven’s injury is ‘not thought to be serious’ after the Manchester United youngster was forced off against Leicester City.